Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Lewis

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
ACS Medicinal Chemistry Letters|August 27, 2016
CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis ModelAndrew D Cansfield, Tammy Ladduwahetty, Mihiro Sunose, et al.
Nature Neuroscience|February 17, 2025
Brain pericytes and perivascular fibroblasts are stromal progenitors with dual functions in cerebrovascular regeneration after strokeLouis-Philippe Bernier, Jasmin K Hefendehl, R Wilder Scott, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2011
Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonistMairi Sime, Amanda C Allan, Paul Chapman, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2Josie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
ACS Medicinal Chemistry Letters|August 27, 2016
CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis ModelAndrew D Cansfield, Tammy Ladduwahetty, Mihiro Sunose, et al.
Nature Neuroscience|February 17, 2025
Brain pericytes and perivascular fibroblasts are stromal progenitors with dual functions in cerebrovascular regeneration after strokeLouis-Philippe Bernier, Jasmin K Hefendehl, R Wilder Scott, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2011
Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonistMairi Sime, Amanda C Allan, Paul Chapman, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2Josie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Pageof 4